Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01539941 · ClinicalTrials.gov registry record · Phase 1
Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care
A Phase 1 study, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01539941 is a Phase 1 study that has completed, run by The National Center on Addiction and Substance Abuse at Columbia University. The registered enrollment target is 14 participants.
The verdict
NCT01539941, a Phase 1 study, has completed, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The goal of this proposal is to develop and pilot a brief protocol designed to systematically integrate pharmacological interventions for attention deficit hyperactivity disorder (ADHD) into behavioral treatment services for adolescent substance users with comorbid ADHD in everyday care. ADHD is a prevalent co-occurring condition for adolescent substance use (ASU) that can significantly impede successful ASU treatment but is vastly under-diagnosed and undertreated among ASU clients in agency settings. Moreover, ADHD medication acceptance and compliance is particularly difficult to achieve in high-risk adolescent populations.
Interventions
- BEHAVIORAL Medication integration protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01539941
The ClinicalTrials.gov registry entry for NCT01539941 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medication integration protocol is the first listed.
NCT01539941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01539941 about?
NCT01539941 is a clinical study titled "Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care". The goal of this proposal is to develop and pilot a brief protocol designed to systematically integrate pharmacological interventions for attention deficit hyperactivity disorder (ADHD) into behavioral treatment services for adolescent substance users with comorbid ADHD in everyday care. ADHD is a p...
What is the current status of trial NCT01539941?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2011-08. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01539941?
The interventions under investigation include: Medication integration protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT01539941?
This trial is sponsored by The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.